Topic

New York

A collection of 427 issues

How to Get Strimvelis Gene Therapy Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Strimvelis Covered by Cigna in New York Strimvelis requires prior authorization from Cigna as a non-formulary, investigational gene therapy available only at SR-TIGET in Milan, Italy. The fastest path to approval involves: (1) confirming your plan covers international/out-of-network care, (2) submitting Cigna's Commercial Drug

Renewing Alecensa (alectinib) Coverage with Humana in New York: Annual Requirements, Timeline, and Appeals Process

Answer Box: Renewing Your Alecensa Coverage Humana Medicare Advantage requires annual prior authorization renewal for Alecensa (alectinib) with updated clinical documentation. Start the renewal process 60 days before your current approval expires. Submit: updated ALK-positive test results, recent imaging showing stable disease or response (RECIST criteria), current lab values (CBC,

The Requirements Checklist to Get Firazyr (icatibant injection) Covered by Blue Cross Blue Shield in New York

Answer Box: Getting Firazyr Covered by BCBS in New York Eligibility: Patients with confirmed hereditary angioedema (HAE) diagnosis and documented C1-inhibitor deficiency can get Firazyr covered through Blue Cross Blue Shield prior authorization in New York. Fastest Path: (1) Gather HAE lab results (C4, C1-INH levels) and attack history, (2)

How to Get Orladeyo (berotralstat) Covered by Humana in New York: Appeals, Forms & State Protections

Answer Box: Getting Orladeyo (berotralstat) Covered by Humana in New York Orladeyo (berotralstat) requires prior authorization from Humana in New York for hereditary angioedema (HAE) prophylaxis. The fastest path to approval: ensure your HAE specialist submits complete documentation including C1-INH lab results, attack history, and prior therapy failures through Humana&

How to Get Cresemba (Isavuconazole) Covered by Blue Cross Blue Shield in New York: Complete Coding, Prior Authorization & Appeals Guide

Answer Box: Getting Cresemba Covered by Blue Cross Blue Shield in New York Blue Cross Blue Shield (BCBS) in New York requires prior authorization for Cresemba (isavuconazole) with specific coding and documentation. Use ICD-10 code B44.0 for invasive aspergillosis, HCPCS J1833 for IV billing, and NDC 0469-0420-01 for the

How to Get Amondys 45 (Casimersen) Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Amondys 45 Covered by Cigna in New York Eligibility: Amondys 45 (casimersen) requires Cigna prior authorization for patients with DMD and genetic confirmation of exon 45 skipping amenability. Fastest path: Submit complete PA with CLIA-certified genetic testing, specialist prescription, and current weight-based dosing plan through Cigna provider

How to Get Blenrep (Belantamab Mafodotin) Covered by Humana in New York: Complete Appeal Guide with Forms and Timelines

Answer Box: Getting Blenrep Covered by Humana in New York Current Status: Blenrep (belantamab mafodotin) was re-approved by the FDA on October 23, 2025, for relapsed/refractory multiple myeloma. Most denials occur because the drug requires REMS enrollment and specialty handling. Fastest Path to Approval: 1. Submit Humana's

How to Get Carbaglu (Carglumic Acid) Covered by UnitedHealthcare in New York: Complete PA Guide with Appeals Process

Answer Box: Getting Carbaglu Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Carbaglu (carglumic acid) with 12-month approval periods. Key requirements: genetic confirmation of NAGS deficiency, elevated ammonia levels, and specialist documentation. If denied, New York residents can file internal appeals (180 days) then external review through

The Requirements Checklist to Get Mepsevii (vestronidase alfa-vjbk) Covered by Blue Cross Blue Shield in New York

Answer Box: Getting Mepsevii Covered by Blue Cross Blue Shield in New York Blue Cross Blue Shield in New York requires prior authorization for Mepsevii (vestronidase alfa-vjbk) with strict documentation requirements. Success depends on confirmed MPS VII diagnosis via enzyme assay and genetic testing, specialist prescription from a metabolic disease

Do You Qualify for Tysabri (natalizumab) Coverage by Blue Cross Blue Shield in New York? Complete Decision Tree & Appeals Guide

Answer Box: Tysabri Coverage by BCBS in New York Yes, you likely qualify for Tysabri (natalizumab) coverage by Blue Cross Blue Shield in New York if: you have relapsing multiple sclerosis with documented disease activity, have tried/failed at least one other DMT, and can complete the required TOUCH program